Lymphoma Information Network - Hodgkin's Disease and the Non-Hodgkin's Lymphomas
Site Navigation

Chemotherapy - Vincristine

Title Page

Site Map

Adult Lymphoma
Hodgkin's
DiagnosisTreatmentChemotherapyImmunotherapyTransplantsResources
NHLDiagnosisTreatmentChemotherapyImmunotherapyTransplantsResources

ChildhoodChildhood HDDiagnosisTreatmentChemotherapyRadiationTransplantsChildhood NHLDiagnosisTreatmentChemotherapyRadiationTransplants

Your Host

Vincristine (also called Oncovin or VCR) is a chemotherapy agent used in the treatment of Non-Hodgkin's lymphoma and Hodgkin's Lymphoma / Disease.  It is more often than not given in conjunction with other chemotherapy agents in a multidrug regimen. An antineoplastic, vincristine interferes with the growth of cancer cells - it does this by inhibiting microtubule production on cells. It is in the vinca alkaloid family of drugs which includes vinblastine, a very different drug, sometimes used to treat Hodgkin's Disease. Both vinblastine and vincristine are used in the Stanford V regimen whereas vincristine alone is used in CHOP. Originally derived from the Madagascar periwinkle plant Catharanthus roseus.

Before taking this medicine: Inform the doctor if you have had kidney, liver, or lung disease. It should not be taken while pregnant and not while breast feeding without your doctors' advise.

While taking this medicine: It is important to keep in close contact with the doctor who will monitor dosage and effects. If you have surgery or emergency treatment, tell the doctor/dentist you are taking or have taken this medication.

Short Term Side Effects: Common: nausea and vomiting (ask your doctor about drugs to counteract nausea), fever/chills after dose, cough, shortness of breath, mouth sores, itching, rash, loss of appetite, constipation; Less Common: confusion, faintness, wheezing, peripheral neuropathy (tingling & numbness in the hands and feet); Rare: sudden/severe chest pain, sudden weakness in arms/legs

Long Term Side Effects: hair loss (alopecia) during use - hair growth should return after treatment and lung (pulmonary) toxicity (doses should be monitored), peripheral neuropathy (tingling & numbness in the hands and feet).

Some of the Regimens using Vincristine:

  • MOPP (Hodgkin's Disease - the letter "O" for Oncovin)
  • Stanford V (Hodgkin's Disease - no letters used)
  • CHOP (Non-Hodgkin's - the letter "O")

Vincristine Reference Links:

Manufacturer

  • Eli Lilly (Oncovin)
    Customer Service: (317) 276-2000
    Lilly Corporate Center   Indianapolis, Indiana 46285

Disclaimer: This information is general in nature. Please consult with a doctor or the literature provided with the drugs if you need specific information on a drug. The author is not responsible for missing or inaccurate information and the reader assumes full responsibility for their actions. As always, please consult with medical personnel before undertaking any medical treatment.


For more information on Hodgkin's Disease, please see the following pages: :

For more information on Non-Hodgkin's Lymphoma, please see the following pages: :

The Main Page - gateway to support and more


This page is a work in progress - if you have more complete information, references, or other information please contact the author. The author is not in the medical field and does not warrant the correctness of the material on this page or the sites linked - please take online information and consult with your own medical team to make informed decisions.

Copyright © 1998-2006 Lymphoma Information Network - All Rights Reserved
http://www.LymphomaInfo.net/
Updated June 1, 2006